A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial

Autor: Gennari, A. *, Sun, Z., Hasler-Strub, U., Colleoni, M., Kennedy, M.J., Von Moos, R., Cortés, J., Vidal, M.J., Hennessy, B., Walshe, J., Parraga, K. Amillano, Ribi, K., Bernhard, J., Murillo, S. Morales, Pagani, O., Barbeaux, A., Borstnar, S., Rabaglio-Poretti, M., Maibach, R., Regan, M.M., Jerusalem, G.
Zdroj: In Annals of Oncology March 2018 29(3):661-668
Databáze: ScienceDirect